Variant report
Variant | nsv817862 |
---|---|
Chromosome Location | chr2:49192704-49222572 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr2:49199332..49202324-chr2:49209255..49211522,2 | K562 | blood: | |
2 | chr2:49216778..49218351-chr2:49224131..49226334,2 | MCF-7 | breast: | |
3 | chr2:49173374..49174210-chr2:49199575..49200403,3 | MCF-7 | breast: | |
4 | chr2:49199332..49202324-chr2:49209255..49211522,2 | K562 | blood: | |
5 | chr2:49209751..49211732-chr2:49248932..49250816,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000170820 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs8179692 | chr2:49192704-49192705 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs527812585 | chr2:49192777-49192778 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs369007831 | chr2:49192803-49192804 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs561167575 | chr2:49192831-49192832 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs77721005 | chr2:49192837-49192838 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs78304398 | chr2:49192840-49192841 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs377567991 | chr2:49192857-49192858 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs573967996 | chr2:49192898-49192899 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs539624834 | chr2:49193008-49193009 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs115257945 | chr2:49193017-49193018 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs566558539 | chr2:49193071-49193072 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs537795697 | chr2:49193116-49193117 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs533691756 | chr2:49193139-49193140 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555448651 | chr2:49193144-49193145 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs573253502 | chr2:49193157-49193158 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs144777135 | chr2:49193169-49193170 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs371061522 | chr2:49193172-49193173 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577951801 | chr2:49193230-49193231 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs545175316 | chr2:49193273-49193274 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560571239 | chr2:49193296-49193297 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572495786 | chr2:49193367-49193368 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs148569809 | chr2:49193388-49193389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs556423280 | chr2:49193392-49193393 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2268364 | chr2:49193503-49193504 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184435788 | chr2:49193508-49193509 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs112036514 | chr2:49193509-49193510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs372396444 | chr2:49193511-49193512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs375746667 | chr2:49193521-49193522 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370352010 | chr2:49193527-49193528 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs147746095 | chr2:49193567-49193568 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs71407536 | chr2:49193571-49193572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs552547794 | chr2:49193581-49193582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs562747015 | chr2:49193598-49193599 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs139409773 | chr2:49193631-49193632 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs533309724 | chr2:49193661-49193662 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs551544136 | chr2:49193739-49193740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs189135996 | chr2:49193762-49193763 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs533994251 | chr2:49193774-49193775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs548777483 | chr2:49193782-49193783 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567038826 | chr2:49193819-49193820 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs545237102 | chr2:49193854-49193855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs373896803 | chr2:49193930-49193931 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs527247523 | chr2:49193940-49193941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2300444 | chr2:49193958-49193959 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs145043842 | chr2:49193961-49193962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs147581530 | chr2:49193970-49193971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560771748 | chr2:49193983-49193984 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539006568 | chr2:49193985-49193986 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs2300443 | chr2:49194068-49194069 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs572503157 | chr2:49194089-49194090 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 22522925 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
T-cell lymphomas | 22341440 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49190600-49200400 | Weak transcription | Ovary | ovary |
2 | chr2:49192200-49193200 | Enhancers | Liver | Liver |
3 | chr2:49197000-49197200 | Enhancers | Fetal Brain Male | brain |
4 | chr2:49197800-49198400 | Active TSS | Fetal Brain Male | brain |
5 | chr2:49200400-49200600 | Enhancers | Left Ventricle | heart |
6 | chr2:49201400-49201600 | Enhancers | Left Ventricle | heart |
7 | chr2:49208600-49215600 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
8 | chr2:49210000-49210400 | Enhancers | Brain Germinal Matrix | brain |
9 | chr2:49210400-49211400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
10 | chr2:49210800-49211200 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
11 | chr2:49217400-49218800 | Enhancers | GM12878-XiMat | blood |
12 | chr2:49218200-49220800 | Enhancers | Primary B cells from peripheral blood | blood |
13 | chr2:49218800-49219200 | Flanking Active TSS | GM12878-XiMat | blood |
14 | chr2:49219200-49220800 | Enhancers | Primary B cells from cord blood | blood |
15 | chr2:49219200-49221600 | Enhancers | GM12878-XiMat | blood |
16 | chr2:49221400-49222000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
17 | chr2:49222000-49227400 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |